Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – , the world’s largest life sciences services firm, says it followed study guidelines in an Indian drug trial that now faces a government audit.

Outsourcing Pharma, citing a report from India, said the study of the Theravance antibiotic called Telvancin is being investigated by the Drug Controller general of India.

“All approvals were obtained from the relevant regulatory bodies and ethics committees before the trial began,” Quintiles told Outsourcing Pharma in an e-mail.

For details,

Get the latest news alerts: at Twitter.